SCHEMBL13435807

SCHEMBL13435807

CN(C(=O)N[C@H]1CCCCC/C=C\[C@@H]2C[C@H]2NC(=O)[C@@H]2CCCN2OC1)C(C)(C)C

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8249384 0.71 F2 (0.37) —
SCHEMBL6382019 0.71 F2 (0.37) —
SCHEMBL8244703 0.66 HDAC4 (0.42) —
SCHEMBL19869647 0.66 HDAC4 (0.38) —
SCHEMBL16258958 0.65 OPRM1 (0.34) —
SCHEMBL19870556 0.63 BIRC3 (0.36) —
SCHEMBL14248162 0.62 — —
SCHEMBL7932107 0.62 PPIA (0.33) —
SCHEMBL13951691 0.56 — —
SCHEMBL13888863 0.55 SSTR4 (0.41) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2177523-A1 Novel macrocyclic inhibitors of hepatitis c virus replication Intermune, Inc. (US) 2010-04-21 — — EP disclosed
Send feedback